Drreddys Laboratories reported 118.64M in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aurora Cannabis Inc ACB:CN C$ -86814000 23.72M
Bayer BAYN:GR 2.28B 1.89B
Canopy Growth Corp WEED:CN -114437000 194.91M
Catalent CTLT:US $ 261M 45M
Cipla CIPLA:IN 8.89B 4.3B
Corcept Therapeutics CORT:US $ 31.43M 4.66M
GlaxoSmithKline GSK:LN 181.6B 5.9B
Hikma Pharmaceutical HIK:LN 256M 23M
Horizon Pharma HZNP:US 147M 49.44M
JAZZ PHA JAZZ:US 126.35M 38.8M
Lannett LCI:US $ -23942000 3.64M
Lonza Group LONN:SW 667M 116M
Novartis NOVN:VX 3.32B 176M
Pacira Pharmaceuticals PCRX:US $ 13.18M 8.55M
Prestige Brands PBH:US $ 87.01M 9.59M
Richter Gedeon RICHT:HB 43.45B 5.99B
Sun Pharmaceuticals SUNP:IN 21.51B 5.28B
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Teva Pharmaceutical TEVA:IT 734M 55M